Avalon GloboCare shares are trading higher after the company announced it received a patent from the Hong Kong Intellectual Property Department for its CAR-T and CAR-Natural Killer cell technology.
Avalon GloboCare shares are trading higher after the company announced it received a patent from the Hong Kong Intellectual Property Department for its CAR-T and CAR-Natural Killer cell technology.